Advertisement

Topics

HUMAN BIOLOGICS INTERNATIONAL Company Profile

00:39 EST 19th December 2018 | BioPortfolio

Nil

Location

7150 East Camelback Road, Suite 245
Scottsdale
Arizona
85251
United States of America

Contact

Phone: 480-990-2005
Fax: 480-990-2155
Email: info@humanbiologics.com


News Articles [1547 Associated News Articles listed on BioPortfolio]

Relaunch of ADMA Biologics' human immune globulin under FDA review

ADMA Biologics' amended biologics license application for the relaunch of BIVIGAM, or intravenous immune globulin (human), ha -More- 

WuXi Biologics to Invest $60 Million to Establish a Biologics Production Facility in the United ...

WuXi Biologics is a leading global platform company providing end-to-end solutions for biologics with a mission to accelerate and transform biologics discovery, development and manufacturing Read ...

Prellis Biologics achieves milestone in 3D printing of human tissue with capillaries

(Krause Taylor Associates) Prellis Biologics announced it has reached record speed and resolution in the quest to print human tissue with viable capillaries. The company's proprietary holographic 3D ...

Lone Peak Biologics is Excited to Announce its Newest Groundbreaking Regenerative Product: AmnioShot™

SALT LAKE CITY (PRWEB) July 31, 2018 Lone Peak Biologics is thrilled to announce the latest addition to its industry-leading line ...

Cobra Biologics to investigate continuous manufacturing of AAV for gene therapies

Cobra Biologics, an international contract development and manufacturing organization with a focus on advanced therapy medicinal products has won a £1.5m shared grant from Innovate UK, the United Kin...

Draft guidelines on human gene therapies released by FDA's CBER

The FDA's Center for Biologics Evaluation and Research issued six new draft guidance documents Wednesday regarding human gen -More- 

WuXi Biologics' Chief Quality Officer Received Foreign Post Service Award from FDA

SHANGHAI, Sept. 17, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development...

WuXi Biologics Announced Exclusive Discovery Research with Brii Biosciences for Novel ...

SHANGHAI, Dec. 9, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development a...

Drugs and Medications [437 Associated Drugs and Medications listed on BioPortfolio]

Pvp iodine prep pad [Professional Disposables International, Inc.]

Drug Facts

Sani professional brand sani-hands for kids [Profesional Disposables International, Inc.]

SANI PROFESSIONAL BRAND SANI-HANDS FOR KIDS INSTANT HAND SANITIZING WIPES

Muscle and joint vanishing scent [LIFElabs, a Division of Atico International USA, INC.]

LIFElabs, a Division of Atico International USA, INC.

Sani-hands [Professional Disposables International, Inc.]

SANI PROFESSIONAL BRAND SANI-HANDS FOR KIDS INSTANT HAND SANITIZING WIPES

Pdi sani-hands for kids [Professional Disposables International, Inc.]

PDI SANI-HANDS FOR KIDS ANTIMICROBIAL ALCOHOL GEL HAND WIPES

PubMed Articles [2569 Associated PubMed Articles listed on BioPortfolio]

Advanced formulations for Intranasal Delivery of Biologics.

The global biologics market has been ever increasing over the last decades and is predicted to top Euro 350 by 2020. Facing this scenario, the parenteral route of biologics administration as hitherto ...

Dosing considerations for inhaled biologics.

The number of biologics in the therapeutic development pipeline is increasing including those delivered though inhalation (Morales, 2017; Fathe, 2016). Biologics comprise a broad variety of complex ma...

Considerations for implementing an informatics system to support biologics drug discovery.

A comprehensive, well-functioning and scientifically aware informatics environment is of the utmost importance in supporting effective drug discovery programs. However, implementing such a system can,...

Efficacy and safety of biologics targeting IL-17 and IL-23 in the treatment of moderate-to-severe plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials.

Numerous biologics are currently licensed for the treatment of psoriasis, including new drugs targeting interleukin-17 (IL-17) and interleukin-23 (IL-23). This meta-analysis evaluated the short-term (...

In further defense of nonclinical abuse liability testing of biologics.

Risk assessment is not a choice. Drug Abuse Liability (DAL) is mandated under international and national drug control statutes for all drugs targeting the CNS. Once administered to humans many biologi...

Clinical Trials [3796 Associated Clinical Trials listed on BioPortfolio]

A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)

The purpose of this study is to compare the efficacy of Biologics + Methotrexate with Biologics + Tacrolimus measured by the disease activity score 28 (DAS28) erythrocyte sedimentation rat...

Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

The patients included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health plan...

Golimumab Safety and Surveillance Program Using the Ingenix NHI Database

The participants included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health ...

Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease

"RUN-CD" is an investigator initiated "Non interventional Trial" on biologics in Crohn´s Disease (CD) patients in Germany with a prospective documentation of effectiveness in induction an...

Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity

Rationale/hypothesis: Moderate-to-severe psoriasis can be treated with biologics. Objective To investigate whether the dose of biologics can be reduced in patients with psoriasis with sta...

Companies [2543 Associated Companies listed on BioPortfolio]

Prellis Biologics, Inc.

Prellis Biologics, Inc. developed the first holographic printing system able to match and accurately replicate human organ and tissue structures for R&D and organ transplan...

HUMAN BIOLOGICS INTERNATIONAL

Nil

MSD Biologics (UK) Limited

Avecia Biologics was acquired in February 2010 by MSD, the UK subsidiary of Merck & Co Inc, the world’s second largest pharmaceutical company. MSD Billingham is one of the world's leading contract ...

Prellis Biologics

Prellis Biologics aims to eliminate the wait list for human organ transplants and speed up development of vital new drug therapies. Using innovations in 3D printing and stem cell ...

GT Biologics

GT Biologics is focused on the research and development of Live Biotherapeutics (LBPs) for the treatment of autoimmune diseases. GT Biologics aim to deliver a new class of medicine based on the po...

More Information about "HUMAN BIOLOGICS INTERNATIONAL" on BioPortfolio

We have published hundreds of HUMAN BIOLOGICS INTERNATIONAL news stories on BioPortfolio along with dozens of HUMAN BIOLOGICS INTERNATIONAL Clinical Trials and PubMed Articles about HUMAN BIOLOGICS INTERNATIONAL for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of HUMAN BIOLOGICS INTERNATIONAL Companies in our database. You can also find out about relevant HUMAN BIOLOGICS INTERNATIONAL Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record